These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

194 related articles for article (PubMed ID: 32783769)

  • 1. Immunogenicity and safety of purified vero cell-cultured rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in the healthy Chinese subjects: a randomized, double-blind, positive controlled phase 3 clinical trial.
    Shen H; Wang Z; Yang B; Cai K; Jiang C; Xie R; Xiao H; Ren Q; Qi Z; Li J; Li Q; Ye J; Zhan F
    Hum Vaccin Immunother; 2021 Feb; 17(2):351-357. PubMed ID: 32783769
    [No Abstract]   [Full Text] [Related]  

  • 2. Immunogenicity and safety of purified chick-embryo cell rabies vaccine under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese children 6 to 17 years old and adults over 50 years: a randomized open-label study.
    Li R; Li Y; Wen S; Wen H; Nong Y; Mo Z; Xie F; Pellegrini M
    Hum Vaccin Immunother; 2015; 11(2):435-42. PubMed ID: 25692350
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A randomized open-labeled study to demonstrate the non-inferiority of purified chick-embryo cell rabies vaccine administered in the Zagreb regimen (2-1-1) compared with the Essen regimen in Chinese adults.
    Ma J; Wang H; Li J; Chang L; Xie Y; Liu Z; Zhao Y; Malerczyk C
    Hum Vaccin Immunother; 2014; 10(10):2805-12. PubMed ID: 25483635
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity and safety of purified vero cell rabies vaccine (PVRV) produced by Liaoning Cheng Da Co. under Zagreb 2-1-1 or 5-dose Essen regimen in Chinese adults aged 50 and above.
    Wang J; Luo F; Feng Z; Li L; Bai Y; Ai X; Ma J; Zhang Z; Shi N
    Hum Vaccin Immunother; 2017 Jan; 13(1):144-150. PubMed ID: 28045585
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety, immunogenicity of lyophilized purified vero cell cultured rabies vaccine administered in Zagreb and Essen regimen in post-exposure subjects: A post-marketing, parallel control clinical trial.
    Zhang L; Huang S; Cai L; Zhu Z; Chen J; Lu S; Zhu Z; Zhang M; Fang Y; Hu Q
    Hum Vaccin Immunother; 2021 Aug; 17(8):2547-2553. PubMed ID: 33631078
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparative study on the immunogenicity and safety of a purified chick embryo cell rabies vaccine (PCECV) administered according to two different simulated post exposure intramuscular regimens (Zagreb versus Essen).
    Mahendra BJ; Narayana DA; Agarkhedkar S; Ravish HS; Harish BR; Agarkhedkar S; Madhusudana SN; Belludi A; Ahmed K; Jonnalagedda R; Vakil H; Bhusal C; Arora AK
    Hum Vaccin Immunother; 2015; 11(2):428-34. PubMed ID: 25692792
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized, Double-Blind, Controlled Phase III Clinical Trial to Evaluate the Immunogenicity and Safety of a Lyophilized Human Rabies Vaccine (Vero Cells) in Healthy Participants Aged 10-60 Years Following Essen and Zagreb Vaccination Procedures.
    Wu X; Li J; Zhou L; Chen J; Jin Z; Meng Q; Chai J; Gao H; Wang Y; Zhao D; Wu H; Yu J; Chen N; Wang Y; Lin Y; Huang P; Li Y; Zhang Y
    Vaccines (Basel); 2023 Aug; 11(8):. PubMed ID: 37631879
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunogenicity, safety and antibody persistence of a purified vero cell cultured rabies vaccine (Speeda) administered by the Zagreb regimen or Essen regimen in post-exposure subjects.
    Shi N; Zhang Y; Zheng H; Zhu Z; Wang D; Li S; Li Y; Yang L; Zhang J; Bai Y; Lu Q; Zhang Z; Luo F; Yu C; Li L
    Hum Vaccin Immunother; 2017 Jun; 13(6):1-8. PubMed ID: 28121231
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunogenicity and Safety of a Purified Vero Rabies Vaccine-Serum Free, Compared With 2 Licensed Vaccines, in a Simulated Rabies Post-Exposure Regimen in Healthy Adults in France: A Randomized, Controlled, Phase 3 Trial.
    Pineda-Peña AC; Jiang Q; Petit C; Korejwo-Peyramond J; Donazzolo Y; Latreille M; Homery MC; Babin V; Benamor S; Pichon S; Guinet-Morlot F; Minutello AM
    Clin Infect Dis; 2024 Jun; 78(6):1748-1756. PubMed ID: 38478634
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of safety and immunogenicity of purified chick embryo cell vaccine using Zagreb and Essen regimens in patients with category II exposure in China.
    Hu Q; Liu MQ; Zhu ZG; Zhu ZR; Lu S
    Hum Vaccin Immunother; 2014; 10(6):1645-9. PubMed ID: 24632727
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Comparison of safety and immunogenicity of PVRV and PCECV immunized in patients with WHO category II animal exposure: a study based on different age groups.
    Fang Y; Chen L; Liu MQ; Zhu ZG; Zhu ZR; Hu Q
    PLoS Negl Trop Dis; 2014 Dec; 8(12):e3412. PubMed ID: 25522244
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A simulated, randomized study on the safety and immunogenicity of three consecutive commercial-scale batches of the CTN-1V strain human rabies vaccine to verify the inter-batch consistency.
    Zhou L; Liu J; Li J; Liu X; Zhang J; Nie F; Chen J; Chai J; Lv J; Wang M; Yu J; Wu W; Li Y; Zhang Y
    Hum Vaccin Immunother; 2022 Nov; 18(6):2138049. PubMed ID: 36409064
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Safety and immunogenicity of a serum-free purified Vero rabies vaccine in comparison with the rabies human diploid cell vaccine (HDCV; Imovax® Rabies) administered in a simulated rabies post-exposure regimen in healthy adults.
    Pichon S; Moureau A; Petit C; Kirstein JL; Sheldon E; Guinet-Morlot F; Minutello AM
    Vaccine; 2024 Apr; 42(10):2553-2559. PubMed ID: 38105138
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A next-generation, serum-free, highly purified Vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab® when administered according to a post-exposure regimen in healthy children and adults in China.
    Li R; Huang L; Li J; Mo Z; He B; Wang Y; Wu X; Minutello M; Guinet-Morlot F; Pichon S
    Vaccine; 2013 Dec; 31(50):5940-7. PubMed ID: 24148575
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intradermal post-exposure rabies vaccination with purified Vero cell rabies vaccine: Comparison of a one-week, 4-site regimen versus updated Thai Red Cross regimen in a randomized non-inferiority trial in the Philippines.
    Quiambao BP; Ambas C; Diego S; Bosch Castells V; Korejwo J; Petit C; Houillon G
    Vaccine; 2019 Apr; 37(16):2268-2277. PubMed ID: 30890382
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rabies post-exposure prophylaxis vaccination with purified chick embryo cell vaccine (PCECV) and purified Vero cell rabies vaccine (PVRV) in a four-site intradermal schedule (4-0-2-0-1-1): an immunogenic, cost-effective and practical regimen.
    Ambrozaitis A; Laiskonis A; Balciuniene L; Banzhoff A; Malerczyk C
    Vaccine; 2006 May; 24(19):4116-21. PubMed ID: 16545510
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The immunogenicity and safety of vaccination with purified Vero cell rabies vaccine (PVRV) in China under a 2-1-1 regimen.
    Liu H; Huang G; Tang Q; Li J; Cao S; Fu C; Cao Q; Liu B; Pan H; Wang M
    Hum Vaccin; 2011 Feb; 7(2):220-4. PubMed ID: 21311216
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Safety and immunogenicity of three dose levels of an investigational, highly purified Vero cell rabies vaccine: A randomized, controlled, observer-blinded, Phase II study with a simulated post-exposure regimen in healthy adults.
    Pichon S; Guinet-Morlot F; Saleh J; Essink B; Pineda-Peña AC; Moureau A; Petit C; Minutello AM
    Hum Vaccin Immunother; 2023 Dec; 19(3):2275453. PubMed ID: 37921410
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunological Effect of aGV Rabies Vaccine Administered Using the Essen and Zagreb Regimens: A Double-Blind, Randomized Clinical Trial.
    Miao L; Shi L; Yang Y; Yan K; Sun H; Mo Z; Li L
    Viral Immunol; 2018 Apr; 31(3):242-248. PubMed ID: 29394147
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A serum-free, purified vero cell rabies vaccine is safe and as immunogenic as the reference vaccine Verorab for pre-exposure use in healthy adults: results from a randomized controlled phase-II trial.
    Pichon S; Guinet-Morlot F; Minutello M; Donazzolo Y; Rouzier R; Chassard D; Fitoussi S; Hou V
    Vaccine; 2013 Apr; 31(18):2295-301. PubMed ID: 23510665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.